| Identification | Back Directory | [Name]
4-Aza-5a-androstan-1-ene-3-one-17b-carboxylic acid | [CAS]
104239-97-6 | [Synonyms]
M4 ACID
Dutasteride EP Impurity A
4-Aza-5a-androstan-1-en-one-16b-carboxylic acid
3-Oxo-4-aza-5α-androst-1-ene-17-carboxylic acid
3-Oxo-4-aza-5a-androst-1-ene-17b-carboxylicAcid
3-Oxo-4-aza-5a-androst-1-ene-17-carboxylic Acid
3-Oxo-4-aza-5α-αndrost-1-ene-17β-carboxylic Acid
4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid
4-Aza-5a-androstan-1-ene-3-one-17b-carboxylic acid
4-AZA-5A-ANDROSTAN-1-ENE-3-ONE-17β-CARBOXYLIC ACID
4-Aza-5a-androsten-1-ene-3-one-17b-carboxylic acid
4-AZA-5ALPHA-ANDROSTA-1-EN-3-ONE-17BETA-CARBOXYLIC ACID
(5APHA,17BETA)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXYLIC ACID
(5alpha,17beta)-3-Oxo-4-azaandrost-1-ene-17-carboxylic acid
4-aza-5α-androstan-1-ene-3-one-17β-carboxylic acid (M4Acid)
Finasteride related: (5apha,17beta)-3-oxo-4-Azaandrost-1-ene-17-carboxylic acid
1H-Indeno[5,4-f]quinoline-7-carboxylic acid, 2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-diMethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)- | [EINECS(EC#)]
1592732-453-0 | [Molecular Formula]
C19H27NO3 | [MDL Number]
MFCD08063794 | [MOL File]
104239-97-6.mol | [Molecular Weight]
317.42 |
| Chemical Properties | Back Directory | [Appearance]
Off-White Powder | [Melting point ]
295-297 °C | [Boiling point ]
527.3±50.0 °C(Predicted) | [density ]
1.166 | [storage temp. ]
2-8°C | [solubility ]
Acetonitrile (Slightly), DMSO (Slightly), Methanol (Slightly, Sonicated) | [form ]
Solid | [pka]
4.80±0.60(Predicted) | [color ]
Off-White to Pale Brown |
| Hazard Information | Back Directory | [Chemical Properties]
Off-White Powder | [Uses]
A novel intermediate in the synthesis of Finasteride and Dutasteride, a 5α-reductase inhibitors used for treatment of benign prostatic hyperplasia acne, seborrhea, female hirsutism, prostatitis, and p
rostatic carcinoma and other hyperandrogenetic related disorders. | [Uses]
A novel intermediate in the synthesis of Finasteride, a 5α-reductase inhibitor used for treatment of benign prostatic hyperplasia acne, seborrhea, female hirsutism, prostatitis, and prostatic carcinoma and other hyperandrogenetic related disorders. | [Uses]
An intermediate in the synthesis of Finasteride, am onhibitor of 5a-reductase, the enzyme which converts testosterone to the more potent androgen, 5a-dihydrotestosterone |
|
|